Results

Eli Lilly and Company

03/03/2021 | Press release | Distributed by Public on 03/03/2021 05:59

Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial